Total Payments
$357,481
2024 Payments
$74,545
Companies
45
Transactions
911
Medicare Patients
685
Medicare Billing
$298,053
Payment Breakdown by Category
Other$293,855 (82.2%)
Travel$37,101 (10.4%)
Food & Beverage$24,551 (6.9%)
Consulting$1,641 (0.5%)
Education$333.44 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $293,855 | 152 | 82.2% |
| Travel and Lodging | $37,101 | 106 | 10.4% |
| Food and Beverage | $24,551 | 641 | 6.9% |
| Consulting Fee | $1,641 | 2 | 0.5% |
| Education | $333.44 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $107,135 | 119 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $66,436 | 154 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53,221 | 71 | $0 (2024) |
| Lilly USA, LLC | $47,540 | 52 | $0 (2024) |
| Novo Nordisk Inc | $37,529 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $29,643 | 139 | $0 (2024) |
| BIOTRONIK INC. | $2,794 | 18 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,756 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,707 | 75 | $0 (2024) |
| Abbott Laboratories | $797.73 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74,545 | 105 | Novo Nordisk Inc ($37,252) |
| 2023 | $134,189 | 218 | Lilly USA, LLC ($42,820) |
| 2022 | $91,612 | 158 | Merck Sharp & Dohme LLC ($38,209) |
| 2021 | $37,669 | 145 | Janssen Pharmaceuticals, Inc ($19,700) |
| 2020 | $9,327 | 76 | AstraZeneca Pharmaceuticals LP ($7,836) |
| 2019 | $2,355 | 68 | Sun Pharmaceutical Industries Inc. ($466.73) |
| 2018 | $2,624 | 54 | Celgene Corporation ($381.87) |
| 2017 | $5,159 | 87 | BIOTRONIK INC. ($2,136) |
All Payment Transactions
911 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $1,341.00 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,938.00 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,037.50 | General |
| 10/29/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $127.03 | General |
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $120.88 | General |
| 10/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,006.25 | General |
| 10/15/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $156.11 | General |
| 10/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $86.46 | General |
| 10/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,938.00 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.54 | General |
| Category: Cardiovascular | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,006.25 | General |
| 09/19/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $157.99 | General |
| 09/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: DIABETES | ||||||
| 08/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 338 | 2,301 | $1.0M | $231,724 |
| 2022 | 3 | 93 | 268 | $109,377 | $23,639 |
| 2021 | 5 | 128 | 251 | $74,710 | $22,208 |
| 2020 | 4 | 126 | 224 | $68,020 | $20,483 |
Total Patients
685
Total Services
3,044
Medicare Billing
$298,053
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 1,028 | $483,361 | $102,481 | 21.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 37 | 361 | $248,195 | $63,637 | 25.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 577 | $158,675 | $38,249 | 24.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 29 | 162 | $64,450 | $14,374 | 22.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 66 | $33,000 | $9,590 | 29.1% |
| 93307 | Ultrasound of heart | Facility | 2023 | 57 | 61 | $8,479 | $2,220 | 26.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 17 | 17 | $5,625 | $975.12 | 17.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 17 | 29 | $696.00 | $197.15 | 28.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 197 | $87,302 | $16,942 | 19.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 23 | $11,500 | $3,830 | 33.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 47 | 48 | $10,575 | $2,866 | 27.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 163 | $44,825 | $14,403 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 31 | $15,500 | $5,311 | 34.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 25 | 25 | $4,125 | $1,521 | 36.9% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Facility | 2021 | 20 | 20 | $9,000 | $575.00 | 6.4% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Facility | 2021 | 12 | 12 | $1,260 | $398.40 | 31.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 38 | 133 | $36,575 | $11,983 | 32.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 30 | 31 | $15,275 | $5,420 | 35.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 37 | 38 | $6,270 | $2,427 | 38.7% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Facility | 2020 | 21 | 22 | $9,900 | $653.98 | 6.6% |
About Dr. Bao Bui, M.D
Dr. Bao Bui, M.D is a Cardiovascular Disease healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801099593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bao Bui, M.D has received a total of $357,481 in payments from pharmaceutical and medical device companies, with $74,545 received in 2024. These payments were reported across 911 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($293,855).
As a Medicare-enrolled provider, Bui has provided services to 685 Medicare beneficiaries, totaling 3,044 services with total Medicare billing of $298,053. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Fountain Valley, CA
- Active Since 06/08/2007
- Last Updated 03/12/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1801099593
Products in Payments
- VERQUVO (Drug) $107,095
- JARDIANCE (Drug) $97,391
- XARELTO (Drug) $66,768
- FARXIGA (Drug) $28,418
- Ozempic (Drug) $17,873
- Kerendia (Drug) $1,756
- ENTRESTO (Drug) $830.70
- Repatha (Biological) $662.27
- BRILINTA (Drug) $631.68
- ELIQUIS (Drug) $588.81
- Protego (Device) $583.00
- Impella (Device) $571.71
- COSENTYX (Biological) $525.42
- Otezla (Drug) $520.48
- Xience Alpine cornary stent system (Device) $516.86
- ILUMYA (Biological) $466.73
- Cimzia (Drug) $348.84
- TALTZ (Drug) $301.25
- SILIQ (Drug) $293.03
- LifeVest (Device) $286.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fountain Valley
Dr. Robert Greenfield, Md, MD
Cardiovascular Disease — Payments: $67,004
Cardiovascular Disease $67,004
Dr. Arvind Nirula, M.d, M.D
Cardiovascular Disease — Payments: $20,973
Cardiovascular Disease $20,973
Dr. Sarah Elsayed, M.d, M.D
Cardiovascular Disease — Payments: $12,248
Cardiovascular Disease $12,248
Dr. Amanda Donohue, D.o, D.O
Cardiovascular Disease — Payments: $6,294
Cardiovascular Disease $6,294
Tuan Nguyen, M.d, M.D
Cardiovascular Disease — Payments: $4,674
Cardiovascular Disease $4,674
Dr. Steven Schiff, Md, Facc, Inc, MD, FACC, INC
Cardiovascular Disease — Payments: $4,122
Cardiovascular Disease $4,122